About 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine
3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine (PubChem CID 165075911) has the molecular formula C69H59BBr2F12N10O9S2
and a molecular weight of 1635.02 g/mol. Its IUPAC name is 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine.
Frequently Asked Questions
What is the IUPAC name of 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine?
The IUPAC name of 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine (CID 165075911) is 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine.
What is the SMILES notation for 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine?
The canonical SMILES for 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine is C=Cc1ncc(Br)cc1C(=O)OC.CC1(C)OB(c2ccc3nc(N)sc3c2)OC1(C)C.NCc1cc(OC(F)(F)F)ccc1F.Nc1nc2ccc(-c3cnc4c(c3)C(=O)N(Cc3cc(OC(F)(F)F)ccc3F)CC4)cc2s1.O=C1c2cc(Br)cnc2CCN1Cc1cc(OC(F)(F)F)ccc1F.
What is the InChIKey of 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine?
The InChIKey is UHKBMUFDUKLFGQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H16F4N4O2S.C16H11BrF4N2O2.C13H17BN2O2S.C9H8BrNO2.C8H7F4NO/c24-17-3-2-15(33-23(25,26)27)7-14(17)11-31-6-5-18-16(21(31)32)8-13(10-29-18)12-1-4-19-20(9-12)34-22(28)30-19;17-10-6-12-14(22-7-10)3-4-23(15(12)24)8-9-5-11(1-2-13(9)18)25-16(19,20)21;1-12(2)13(3,4)18-14(17-12)8-5-6-9-10(7-8)19-11(15)16-9;1-3-8-7(9(12)13-2)4-6(10)5-11-8;9-7-2-1-6(3-5(7)4-13)14-8(10,11)12/h1-4,7-10H,5-6,11H2,(H2,28,30);1-2,5-7H,3-4,8H2;5-7H,1-4H3,(H2,15,16);3-5H,1H2,2H3;1-3H,4,13H2.
What are the key properties of 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine?
3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine has a molecular weight of 1635.02 g/mol, XLogP of 15.89, 12 rotatable bonds, 3 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-amino-1,3-benzothiazol-6-yl)-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;3-bromo-6-[[2-fluoro-5-(trifluoromethoxy)phenyl]methyl]-7,8-dihydro-1,6-naphthyridin-5-one;[2-fluoro-5-(trifluoromethoxy)phenyl]methanamine;methyl 5-bromo-2-ethenylpyridine-3-carboxylate;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine is sourced from PubChem (CID 165075911), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).